Perbak Capital Partners LLP Sells 9,383 Shares of Molina Healthcare, Inc. (NYSE:MOH)

Perbak Capital Partners LLP lowered its position in Molina Healthcare, Inc. (NYSE:MOH - Free Report) by 86.5% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,463 shares of the company's stock after selling 9,383 shares during the quarter. Perbak Capital Partners LLP's holdings in Molina Healthcare were worth $426,000 at the end of the most recent quarter.

A number of other institutional investors have also recently added to or reduced their stakes in the company. Versant Capital Management Inc increased its holdings in Molina Healthcare by 83.1% in the fourth quarter. Versant Capital Management Inc now owns 163 shares of the company's stock valued at $47,000 after buying an additional 74 shares during the last quarter. Wingate Wealth Advisors Inc. bought a new stake in Molina Healthcare in the fourth quarter valued at about $52,000. Hurley Capital LLC bought a new stake in Molina Healthcare in the fourth quarter valued at about $55,000. EverSource Wealth Advisors LLC increased its holdings in Molina Healthcare by 81.5% in the fourth quarter. EverSource Wealth Advisors LLC now owns 196 shares of the company's stock valued at $57,000 after buying an additional 88 shares during the last quarter. Finally, Harvest Fund Management Co. Ltd increased its holdings in Molina Healthcare by 895.0% in the fourth quarter. Harvest Fund Management Co. Ltd now owns 199 shares of the company's stock valued at $58,000 after buying an additional 179 shares during the last quarter. Institutional investors and hedge funds own 98.50% of the company's stock.

Molina Healthcare Price Performance

Molina Healthcare stock traded down $13.51 on Thursday, reaching $313.50. The company's stock had a trading volume of 671,381 shares, compared to its average volume of 676,957. The company has a debt-to-equity ratio of 0.69, a quick ratio of 1.62 and a current ratio of 1.62. The company has a market cap of $16.99 billion, a price-to-earnings ratio of 15.35, a PEG ratio of 1.06 and a beta of 0.70. The business's fifty day moving average price is $322.03 and its 200 day moving average price is $307.37. Molina Healthcare, Inc. has a twelve month low of $262.32 and a twelve month high of $365.23.

Molina Healthcare (NYSE:MOH - Get Free Report) last posted its quarterly earnings results on Wednesday, April 23rd. The company reported $6.08 earnings per share for the quarter, topping analysts' consensus estimates of $5.96 by $0.12. The business had revenue of $11.15 billion during the quarter, compared to the consensus estimate of $10.86 billion. Molina Healthcare had a net margin of 2.90% and a return on equity of 28.13%. Molina Healthcare's revenue for the quarter was up 12.2% compared to the same quarter last year. During the same period in the previous year, the firm posted $5.73 earnings per share. Equities analysts expect that Molina Healthcare, Inc. will post 24.4 earnings per share for the current fiscal year.

Insider Activity at Molina Healthcare

In other news, Director Steven J. Orlando sold 1,000 shares of the company's stock in a transaction that occurred on Monday, March 3rd. The shares were sold at an average price of $301.33, for a total value of $301,330.00. Following the completion of the transaction, the director now owns 17,375 shares in the company, valued at $5,235,608.75. This represents a 5.44 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Richard M. Schapiro sold 669 shares of the stock in a transaction on Tuesday, April 29th. The stock was sold at an average price of $320.50, for a total transaction of $214,414.50. Following the transaction, the director now owns 11,244 shares of the company's stock, valued at $3,603,702. The trade was a 5.62 % decrease in their position. The disclosure for this sale can be found here. Corporate insiders own 1.10% of the company's stock.

Wall Street Analyst Weigh In

Several equities analysts have recently commented on the company. Robert W. Baird reaffirmed a "neutral" rating and set a $375.00 target price (up from $331.00) on shares of Molina Healthcare in a report on Tuesday, April 15th. Barclays upped their target price on Molina Healthcare from $339.00 to $362.00 and gave the company an "equal weight" rating in a report on Friday, April 25th. Stephens reaffirmed an "equal weight" rating and set a $345.00 target price on shares of Molina Healthcare in a report on Thursday, February 6th. Sanford C. Bernstein assumed coverage on Molina Healthcare in a report on Tuesday, April 22nd. They set an "outperform" rating and a $414.00 target price for the company. Finally, Wells Fargo & Company raised Molina Healthcare from an "equal weight" rating to an "overweight" rating and upped their target price for the company from $295.00 to $372.00 in a report on Wednesday, March 5th. Nine research analysts have rated the stock with a hold rating and seven have given a buy rating to the company's stock. Based on data from MarketBeat.com, the company presently has a consensus rating of "Hold" and a consensus price target of $365.38.

Molina Healthcare Company Profile

Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.